APA

Yang Y., Jiang H., Gao H., Kong J., Zhang P., Hu S., Shi B., Zhang P., Yao M. & Li Z. (20121113). The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. : Neoplasia (New York, N.Y.).

Chicago

Yang Yaqiong, Jiang Hua, Gao Huiping, Kong Juan, Zhang Pengwei, Hu Suwen, Shi Bizhi, Zhang Pengfei, Yao Ming and Li Zonghai. 20121113. The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. : Neoplasia (New York, N.Y.).

Harvard

Yang Y., Jiang H., Gao H., Kong J., Zhang P., Hu S., Shi B., Zhang P., Yao M. and Li Z. (20121113). The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. : Neoplasia (New York, N.Y.).

MLA

Yang Yaqiong, Jiang Hua, Gao Huiping, Kong Juan, Zhang Pengwei, Hu Suwen, Shi Bizhi, Zhang Pengfei, Yao Ming and Li Zonghai. The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. : Neoplasia (New York, N.Y.). 20121113.